Construction of a Shuttle Vector for Protein Secretory Expression in Bacillus Subtilis and the Application of the Mannanase Func
Total Page:16
File Type:pdf, Size:1020Kb
J. Microbiol. Biotechnol. (2014), 24(4), 431–439 http://dx.doi.org/10.4014/jmb.1311.11009 Research Article jmb Construction of a Shuttle Vector for Protein Secretory Expression in Bacillus subtilis and the Application of the Mannanase Functional Heterologous Expression Su Guo, Jia-jie Tang, Dong-zhi Wei, and Wei Wei* State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai 200237, People’s Republic of China Received: November 6, 2013 Revised: December 11, 2013 We report the construction of two Bacillus subtilis expression vectors, pBNS1/pBNS2. Both Accepted: December 24, 2013 vectors are based on the strong promoter P43 and the ampicillin resistance gene expression cassette. Additionally, a fragment with the Shine-Dalgarno sequence and a multiple cloning site (BamHI, SalI, SacI, XhoI, PstI, SphI) were inserted. The coding region for the amyQ (encoding an amylase) signal peptide was fused to the promoter P43 of pBNS1 to construct the First published online December 30, 2013 secreted expression vector pBNS2. The applicability of vectors was tested by first generating the expression vectors pBNS1-GFP/pBNS2-GFP and then detecting for green fluorescent *Corresponding author Phone: +86-21-64251803; protein gene expression. Next, the mannanase gene from B. pumilus Nsic-2 was fused to vector Fax: +86-21-64251803; pBNS2 and we measured the mannanase activity in the supernatant. The mannanase total E-mail: [email protected] enzyme activity was 8.65 U/ml, which was 6 times higher than that of the parent strain. Our pISSN 1017-7825, eISSN 1738-8872 work provides a feasible way to achieve an effective transformation system for gene expression in B. subtilis and is the first report to achieve B. pumilus mannanase secretory expression in B. subtilis. Copyright© 2014 by Keywords: Bacillus subtilis, Bacillus pumilus, green fluorescent protein, mannanase, P43 promoter, The Korean Society for Microbiology secretory expression and Biotechnology Introduction compared with other promoters [18]. Furthermore, P43 promoter has been successfully used in recombinant Gram-positive bacterial strains are well known for their proteins production, such as thermostable β-galactosidase, contributions to agricultural, medical, and commercial staphylokinase, and dehydrogenase [18]. enzyme production. Among them, Bacillus subtilis has been Endo-1,4-β-mannanases (β-mannanases, E.C. 3.2.1.78) widely used in recombinant protein production such as catalyze the random hydrolysis of manno-glycosidic bonds enzymes, biochemicals, antibiotics, and insecticides. B. subtilis in mannans and heteromannans. Based upon the amino has been developed as an attractive host because of several acid sequence alignment and hydrophobic cluster analysis, reasons: nonpathogenic and considered as a safe organism, most β-mannanases belong to glycoside hydrolase (GH) no significant bias in codon usage, and capable of secreting families 5, 26, and 113. Endo-1,4-β-mannanases play important functional extracellular proteins directly into the culture roles in basic research, the bioconversion of biomass medium [10, 15]. At present, about 60% of the commercially materials, and various potential industrial applications [3, available enzymes are produced by Bacillus species [11]. A 8, 13]. β-Mannanases from bacteria (Bacillus sp., Aeromonas wide variety of promoters used in B. subtilis have been sp., Streptomyces sp., Pseudomonas sp., or Vibrio sp.), fungi reported [2, 11, 18]. Among them, the constitutive promoter (Penicillium sp., Tyromices sp., Trichosporum sp., Sclerotium P43 is active during the exponential and lag phases of sp., and Aspergillus sp.), plants (Amorphophallus konjac), growth and shows the highest expression capability animals, and in the colonic region of humans were April 2014 ⎪ Vol. 24⎪ No. 4 432 Guo et al. reported in previous research. During recent years, the Table 1. Both E. coli cells and B. subtilis cells were grown in Luria- production of mannanases in recombinant Escherichia coli Bertani (LB) medium at 37oC. Antibiotics were used in this study has been well studied [3, 17]. However, there have been at the following concentrations: ampicillin at 100 µg/ml for E. coli few reports of the mannanases expression in Bacillus subtilis. and kanamycin at 30 µg/ml for B. subtilis. In this study, we report the construction of two B. subtilis Chemicals and Manipulation of DNA expression vectors, pBNS1 and pBNS2, both with the strong Taq DNA polymerase, restriction endonucleases, T4 DNA constitutive promoter P43. The two newly constructed ligase, and pMDTM19-T vector were purchased from Takara vectors can be efficiently transformed into B. subtilis by (Takara Biotechnology, Shanghai, China). Isolated chromosomal electroporation and be used for intra- and extracellular DNA from B. subtilis, plasmids, and gel extraction of DNA were production of recombinant proteins in B. subtilis. In our prepared using the AXYGEN kit (BIOSCIENCE, Shanghai, China). study, the GFP gene and mannanase gene were expressed PCR products and DNA bands were separated by electrophoresis successfully. Both vectors can be used to express exogenous on a 1.0% agarose gel. Transformation of E. coli was carried out genes in B. subtilis and are useful for the large-scale gene using CaCl2-treated 50 µl aliquots of competent cells, and Bacillus expression industry. subtilis cells were transformed by electroporation. Primers used in this study are listed in Table 2. Materials and Methods Construction of Shuttle Expression Vector pBNS1 and pBNS2 First, the original plasmid pBEn (7.4 kb) was constructed using Bacterial Strains, Plasmids, and Culture Conditions plasmids pUB110 (4.5 kb) from B. subtilis and pGEM (2.9 kb) from The following strains were used: Escherichia coli DH5α, Escherichia 3 E. coli. Then, plasmid pBE2a (6.3 kb) was constructed by removing coli BL21(DE3)/pLysS (Invitrogen), B. subtilis 1A751 (Lab collection), a 1.1 kb PvuII cleavage fragment in pBEn. Primers P43-U/P43-D and Bacillus pumilus Nsic-2 (wild strain, accession number: and A1/A2 were used to clone the P43 promoter sequence (from CCTCC AB 2013050. China Center for Type Culture Collection). B. subtilis 168) and signal peptide (from B. amyloliquefaciens), The bacterial strains and plasmids used in this study are listed in respectively. The PCR products were gel extracted and cloned Table 1. Bacterial strains and plasmids used in this study. Strains/plasmids Relevant features Source Strains E. coli DH5α F--, ϕ80d/lacZ∆M15, ∆(lacZYA-argF)U169, deoR, recA1, Lab collection endA1, hsdR17 (rk- mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1 B. subtilis 1A751 apr his npr eglS (DELTA) 102 bglT/bglS (DELTA) EV Lab collection Bacillus pumilus Nsic-2 Wild strain (CCTCC AB 2013050) Lab collection pBNS1-GFP-1A751 B. subtilis 1A751 recombinant strain harboring plasmid pBNS1-GFP; KanR This study pBNS2-GFP-1A751 B. subtilis 1A751 recombinant strain harboring plasmid pBNS2-GFP; KanR This study Plasmids pMDTM19-T Cloning vector; AmpR Takara pUB110 Bacillus cloning vector; KanR Lab collection pGEM3 E. coli expression vector; AmpR Lab collection pMT-P43 pMDTM19-T containing the P43 promoter; AmpR This study pMT-amyQ pMDTM19-T containing the amyQ signal peptide; AmpR This study pMD19-SP pMDTM19-T containing the 188 bp fusion fragment; AmpR This study pBE2a Basic cloning vector; AmpR and kanR This study pBNS1 Bacillus-E. coli shuttle vector; vector for intracellular expression; AmpR and KanR This study pBNS2 Bacillus-E. coli shuttle vector; vector for extracellular expression; AmpR and KanR This study pBNS1-GFP pBNS1-based vector, carrying gfp gene; AmpR and KanR This study pBNS2-GFP pBNS2-based vector, carrying gfp gene; AmpR and KanR This study pBNS2-man pBNS2-based vector, carrying mature mannanase gene; AmpR and KanR This study AmpR, ampicillin resistance; KanR, kanamycin resistance. J. Microbiol. Biotechnol. B. subtilis Secretory Expression and Application 433 Table 2. Synthetic oligonucleotides used in this study. Primer Specificity Amplicon size Nucleotide sequence (5’ → 3’) A1 amyQ signal peptide 96 bp ATGATTCAAAAACGAAAGCGGACAGTT A2 amyQ signal peptide 96 bp TACGGCTGATGTTTTTGTAATCGGCAA P43-U P43 promoter 305 bp CGCGAATTCTGATAGGTGGTATGTTTT (EcoRI) P43-D P43 promoter 305 bp CGCTCTAGATTCATGTGTACATTCCTC (XbaI) F1 Fusion fragment 188 bp GGCTCTAGATTTAAGAAGGAGATATACATATGATTCAAA (XbaI) R1 Fusion fragment 188 bp CTCGAGGAGCTCGTCGACGGATCCTACGGCTGAT R2 Fusion fragment 188 bp GATGGTGATGGCATGCCTGCAGCTCGAGGAGCT R3 Fusion fragment 188 bp GCCAAGCTTGTGATGGTGATGGTGATGGTGATG (Hind) pBNS1-gfp-U GFP reporter gene 771 bp GCCTCTAGATTTAAGAAGGAGATATACATATGAGTAAA (XbaI) pBNS1-gfp-D GFP reporter gene 771 bp GCCAAGCTTGCATGCCTGCAGGTCTGGACATTTATTTGTA (Hind) pBNS2-gfp-U GFP reporter gene 726 bp GCCGGATCCAGTAAAGGAGAAGAA (BamHI) pBNS2-gfp-D GFP reporter gene 726 bp GCCCTCGAGTTATTTGTATAGTTCATCCAT (XhoI) manA-F β-Mannanase gene 1,008 bp GTCTGGATCCCATACTGTGTCGCCTGTGAAT (BamHI) manA-D β-Mannanase gene 1,008 bp GGCCCTCGAGCTCAACGATTGGCGTTAAA (XhoI) Primers P3/P4, A1/A2, pBNS1-gfp-U/pBNS1-gfp-D, pBNS2-gfp-U/pBNS2-gfp-D, and manA-F/manA-D were used to amplify the P43 promoter, the amyQ signal peptide, the GFP reporter gene, and the β-mannanase gene, respectively. Primers F1/R1, R2, and R3 were used for sequential PCR to amplify the 188 bp fusion fragment. The underlined sequences are the restriction sites. The bold underlined sequence are the modified Shine-Dalgarno sequences. into the vector pMD19-T to generate